Neurocrine Biosciences (NBIX) Tops Q4 EPS by 12c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $151.89 +1.60%
EPS Growth %: -12.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -12.4%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $1.24, $0.12 better than the analyst estimate of $1.12. Revenue for the quarter came in at $412 million versus the consensus estimate of $408.87 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Intuit holds investor day, reaffirms fiscal 2027 guidance
- Surgery Partners sells Idaho Falls facilities to Intermountain Health for $797M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
